This Article Full Text Full Text (PDF) All Versions of this Article: 28/4/622    most recent ATVBAHA.107.156059v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Cosentino, F. Articles by Lüscher, T. F. PubMed PubMed Citation Articles by Cosentino, F. Articles by Lüscher, T. F.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:622.)
© 2008 American Heart Association, Inc.

Brief Reviews

Final Common Molecular Pathways of Aging and Cardiovascular Disease

Role of the p66^Shc Protein

Francesco Cosentino; Pietro Francia; Giovanni G. Camici; Pier Giuseppe Pelicci; Massimo Volpe; Thomas F. Lüscher

From Cardiology and Cardiovascular Research (F.C., G.G.C., T.F.L.), University Hospital, Zürich, Institute of Physiology, University of Zürich, and Center for Integrative Human Physiology (ZIHP), Switzerland; Cardiology, 2nd Faculty of Medicine (F.C., P.F., M.V.), University "La Sapienza", Rome, Italy; Experimental Oncology (P.G.P.), European Institute of Oncology, Milan, Italy; and I.R.C.C.S. Neuromed (M.V.), Pozzilli (IS), Italy.

Correspondence to Thomas F. Luscher, MD, Cardiology & Cardiovascular Center, University Hospital, Ramistrasse, 100, CH-8091 Zürich, Switzerland. E-mail karlue{at}usz.unizh.ch

Oxidative stress affects the availability of key-regulators of vascular homeostasis and controls a number of signaling pathways relevant to myocardial and vascular disease. Reactive oxygen species are generated by different intracellular molecular pathways principally located in mitochondria. The notion that mice carrying a targeted mutation of the p66^Shc gene display prolonged lifespan, reduced production of intracellular oxidants, and increased resistance to oxidative stress–induced apoptosis prompted a series of studies aimed at defining the biochemical function of p66^Shc and its possible implication in cardiovascular diseases. Indeed, p66^Shc–/– mice are protected against vascular, cardiac, and renal impairment attributable to hypercholesterolemia, aging, diabetes, and ischemia/reperfusion. The present review focuses on the biochemical and physiological function of the p66^Shc adaptor protein as well as on the mechanisms linking p66^Shc-associated generation of free radicals to the pathophysiology of aging and cardiovascular disease. On the whole, the evidence so far reported and here discussed supports the concept that pharmacological modulation of p66^Shc expression and activity may be a novel and effective target for the treatment of atherosclerotic vascular disease as well as myocardial adaptation to hypertrophic, inflammatory and neuro-hormonal stimuli in the overloaded heart.

Mice carrying a targeted mutation of the p66^Shc gene display reduced production of intracellular oxidants, increased resistance to oxidative stress-induced apoptosis, prolonged lifespan, and are protected against vascular, cardiac, and renal impairment attributable to hypercholesterolemia, aging, diabetes, and ischemia/reperfusion. The present review focuses on the biochemical function of the p66^Shc adaptor protein as well as on the mechanisms linking p66^Shc to the pathophysiology of aging and cardiovascular disease.

Key Words: p66^Shc • aging • atherosclerosis • diabetes • energy metabolism